1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
NanoString Technologies, Inc.

NanoString Technologies, Inc.

NSTGQ
NanoString Technologies, Inc.US flagOther OTC
0.07
USD
+0.00
- -
3.31MMarket Cap
NanoString Technologies, Inc.
NSTGQ
(Other OTC)

Recent

price

0.07

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
1.46
1.94
2.51
4.11
2.67
3.29
4.3
4.84
3.83
3.63
3
3.2
2.74
3.44
Revenue per Share
-2.14
-1.19
-2.75
-3.83
-2.8
-2.4
-2.34
-1.84
-2.78
-1.18
-2.82
-2.54
-3.44
-3.53
Basic EPS, GAAP
-1.61
-1.46
-1.66
-4.2
-2.24
-2.48
-0.5
-2.36
-2.1
-2.81
-2.28
-2.19
-3.27
-2.88
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-7.58
-10.23
-16.59
-9.91
-11.69
-13.4
-13.19
-14.03
-12.49
-13.87
-14.34
-17.44
-19.75
Book Value per Share
- -
-7.58
-10.23
4.12
2.51
1.06
0.61
1.69
1.32
3.01
7.85
3.91
0.99
-1.07
Tangible Book Value per Share
8
9
9
8
18
19
20
24
28
35
39
45
46
47
Basic Weighted Avg Shares
12
18
23
31
48
63
86
115
107
126
117
145
127
162
Sales/Revenue/Turnover
-110.59
-58.97
-71.86
-90.75
-96.7
-65.81
-47.61
-33.24
-65.02
-65.86
-75.05
-74.59
-119.58
-100.07
Operating Margin (%)
1
1
2
2
2
2
3
3
4
5
6
6
8
14
Depreciation Expense
-13
-11
-18
-29
-50
-46
-47
-44
-77
-41
-110
-115
-160
-166
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-108.85
-61.42
-77.08
-93.24
-105.14
-72.74
-54.45
-37.91
-72.52
-32.41
-93.83
-79.44
-125.37
-102.44
Profit Margin (%)
- -
12
20
42
76
62
77
86
89
168
462
375
228
134
Working Capital
- -
1
10
12
30
41
47
49
58
109
198
247
245
242
LT Debt
- -
12
10
31
45
20
12
40
37
104
307
177
46
-51
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
5
5
6
LT Borrowings
227
227
228
LT Finance Leases
17
16
14
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
47
48
48
Market Capitalization
462
190
81

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
252
221
212
Cash, Cash Equivalents & STI
155
118
97
Accounts Receivable, Net
35
43
48
Inventories
47
49
55
Total Current Liabilities
58
62
78
Payables & Accruals
27
30
43
ST Debt
5
5
6
Deferred Revenue
13
14
15

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
64.61%
50.53%
-74.11%
Free Cash Flow
65.67%
25.33%
52.9%
Net Income, GAAP
36.7%
48.78%
38.43%
Sales/Revenue/Turnover
20.62%
3.07%
-12.28%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
32
34
37
42
145
2022
31
32
30
34
127
2023
36
44
48
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.62
-0.6
-0.69
-0.64
-2.54
2022
-0.86
-0.85
-0.79
-0.95
-3.44
2023
-0.88
-0.92
-0.78
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Jiangsu Nanfang Medical Co., Ltd. (603880.SS)
Ginko International Co., Ltd. (8406.TWO)
Shanghai Kindly Enterprise Development Group Co.,LTD. (603987.SS)
NanoString Technologies, Inc. (NSTGQ)
Dynavox Group AB (publ) (DYVOX.ST)
Trajan Group Holdings Limited (TRJ.AX)
Business
NanoString Technologies, Inc. is a life science tools provider specializing in translational research with a focus on spatial biology and gene expression analysis. The company's core products include the nCounter® Analysis System, which offers direct digital detection of up to 800 unique biomarkers including DNA, RNA, and proteins; the GeoMx® Digital Spatial Profiler that enables high-plex spatial profiling of the whole transcriptome and proteome in various tissue samples; the CosMx® Spatial Molecular Imager for high-plex in situ spatial multi-omics analysis at cellular and subcellular resolution; and the AtoMx™ Spatial Informatics Platform supporting spatial biology data analysis. NanoString’s technologies target research applications in genomics, proteomics, clinical research, pharmaceuticals, immunology, neurology, and biopharmaceutical fields, serving life science researchers globally. Founded in 2003 and headquartered in Seattle, Washington, NanoString operates primarily worldwide, with a significant focus on advanced spatial biology solutions that accelerate sample-to-discovery workflows. Over the past 1-2 years, NanoString underwent a significant strategic change through its acquisition by Bruker Corporation in a court-supervised Chapter 11 sale process completed in early 2024. This acquisition included substantially all assets and rights of NanoString's business, including the nCounter®, GeoMx®, CosMx™, and AtoMx™ product lines, for approximately $392.6 million in cash. The acquisition is expected to synergize with Bruker’s portfolio and support growth and profitability, while preserving NanoString’s R&D capabilities. In early 2024, NanoString secured $47.5 million in new financing from existing noteholders to support its restructuring process and ongoing operations, ensuring continued service to its scientific customer base during this transition. Additionally, NanoString has expanded its global presence by overcoming legal restrictions for the CosMx™ platform in Germany, facilitating broader availability of its cutting-edge spatial biology products. These developments highlight the company’s commitment to maintaining leadership in the spatial biology market and advancing scientific discovery worldwide while operating under Bruker's ownership.

Company News

APIChatGPT

  • geekwire.com

    Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

  • businesswire.com

    NanoString Technologies to Be Acquired by Bruker Corporation